Drug Trial Radar · NCT06384157
Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorder
Last checked: Nov 19, 2026Latest source record: Dec 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
300
Actual
Start
Jun 10, 2024
Primary completion
Sep 29, 2025
Study completion Nov 3, 2025
Sponsor
- Lead sponsor
- Indivior Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 25, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to measure safety and efficacy and to determine dose-response relationship for INDV-2000 in participants with moderate to severe Opioid Use Disorder (OUD) who are new to treatment, have recently initiated or completed short-term medically supervised withdrawal with transmucosal (TM) buprenorphine, and are interested in transitioning to a non opioid treatment.
Conditions
- Opioid Use Disorder
Interventions
INDV-2000Drug
INDV-2000 is a highly potent and selective OX1R antagonist that is being developed as a therapy for the treatment of OUD.
PlaceboOther
This is a randomized, double-blind, placebo-controlled study.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion (probability) of participants without treatment failure by the end of Week 12 (Day 85).Time frame: 12 weeks
Locations
35 sites in 1 country. Site status is shown where the registry gives one.
Boyett Health Services Inc
Hamilton, Alabama
Elite Clinical Studies, LLC
Phoenix, Arizona
North County Clinical Research
Oceanside, California
Empire Clinical Research
Pomona, California
Artemis Institute For Clinical Research - San Diego
San Diego, California
Imagine Research of Palm Beach County
Boynton Beach, Florida
Bold City Clinical Research
Jacksonville, Florida
Vitalix Kissimmee
Kissimmee, Florida
Accel Research Sites - Lakeland
Lakeland, Florida
Quantum Clinical Trials
Miami Beach, Florida
Segal Trials Miami Lakes
Miami Lakes, Florida
Clinical Research Center of Florida
Pompano Beach, Florida
Agile Clinical Research Trials
Atlanta, Georgia
Maryland Treatment Centers
Baltimore, Maryland
Vitalix Clinical
Worcester, Massachusetts
Insight Research Institute
Flint, Michigan
Precise Research Centers
Flowood, Mississippi
Arch Clinical Trials
St Louis, Missouri
IMA Clinical Research
Las Vegas, Nevada
Oasis Clinical Research
Las Vegas, Nevada
Richmond Behavioral Associates
Staten Island, New York
Dr Vando Medical Services
The Bronx, New York
Monroe Biomedical Research
Monroe, North Carolina
West Clinical Research
Morehead City, North Carolina
Midwest Clinical Research Center, LLC
Dayton, Ohio
Pahl Pharmaceutical Professionals, LLC
Oklahoma City, Oklahoma
SP Research PLLC Rivus Wellness and Research Insitute
Oklahoma City, Oklahoma
Unity Clinical Research
Oklahoma City, Oklahoma
Prisma Health Addiction Medicine Center
Greenville, South Carolina
Insite Clinical Research, LLC
DeSoto, Texas
El Paso Clinical Trials
El Paso, Texas
HD Research
Houston, Texas
Progressive Clinical Research Llc
Bountiful, Utah
Alpine Research Organisation
Clinton, Utah
Boeson Clinical Research
Provo, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.